Back
Edgewise Therapeutics, Inc. Stock Predictions
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.
Sell
48
EWTX
Edgewise Therapeutics, Inc.
Last Price:
$22.95
Seasonality Move:
-9.77%
7 Day Trial
ALL ACCESS PASS
$
7
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.Edgewise Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Edgewise Therapeutics, Inc. has on average historically risen by 29.5% based on the past 4 years of stock performance.
-
Edgewise Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Edgewise Therapeutics, Inc. Stock Undervalued?The current Edgewise Therapeutics, Inc. [EWTX] share price is $23.57. The Score for EWTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
EWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Edgewise Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Edgewise Therapeutics, Inc. has on average historically risen by 29.5% based on the past 4 years of stock performance.
Edgewise Therapeutics, Inc. Stock Rating
Sell
48
Edgewise Therapeutics, Inc. (EWTX)
is a Sell
Is Edgewise Therapeutics, Inc. overpriced?
-
Edgewise Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Edgewise Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
edgewisetx.com
52-Week Data
52-Week High:
30.48
52-Week Low:
10.60
Prediction Charts
Market Cap:
2.5B
Price in USD:
23.57
Volume:
986K
Beta:
0.27
Technical Analysis
SMA50:
21.58
SMA100:
18.21
SMA200:
16.60
52-Wk Change:
-14.97%
Stock Predictions
-
Is Edgewise Therapeutics, Inc. stock public?Yes, Edgewise Therapeutics, Inc. is a publicly traded company.
-
What is the Edgewise Therapeutics, Inc. stock quote today?The Edgewise Therapeutics, Inc. stock price is 23.57 USD today.
-
How to buy Edgewise Therapeutics, Inc. stock online?You can buy Edgewise Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-12 | 24.01 | 23.62 | 25.00 | 22.77 |
| Dec-15 | 23.67 | 23.94 | 24.31 | 22.99 |
| Dec-16 | 23.81 | 22.77 | 24.31 | 22.55 |
| Dec-17 | 22.73 | 22.31 | 23.25 | 22.26 |
| Dec-18 | 22.31 | 21.15 | 22.81 | 20.14 |
| Dec-19 | 21.85 | 25.55 | 25.64 | 21.49 |
| Dec-22 | 25.20 | 20.94 | 25.39 | 19.76 |
| Dec-23 | 21.02 | 21.75 | 22.29 | 21.02 |
| Dec-24 | 22.46 | 27.29 | 27.38 | 22.15 |
| Dec-26 | 27.29 | 26.35 | 27.39 | 25.36 |
| Dec-29 | 26.31 | 24.62 | 26.54 | 24.57 |
| Dec-30 | 24.07 | 24.54 | 24.95 | 23.95 |
| Dec-31 | 24.55 | 24.82 | 25.03 | 24.07 |
| Jan-5 | 23.64 | 23.57 | 23.87 | 22.98 |
Edgewise Therapeutics, Inc. Earnings
Edgewise Therapeutics, Inc. Earnings Report: Per Share Edgewise Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Edgewise Therapeutics, Inc. Forecast Revenue Growth
Edgewise Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.14 per share.
* Edgewise Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.